COMPOSITIONS AND METHODS FOR TREATMENT OF AORTA FIBROSIS Russian patent published in 2014 - IPC A61K38/17 A61P9/00 

Abstract RU 2536223 C2

FIELD: biotechnologies.

SUBSTANCE: invention relates to compositions containing vasoactive intestinal peptide (VIP) or its fragments, and to application of such compositions in treatment of aorta fibrosis.

EFFECT: group of inventions is effective in treatment and prophylaxis of aorta fibrosis.

10 cl, 4 dwg, 2 ex

Similar patents RU2536223C2

Title Year Author Number
COMPOSITIONS AND METHODS OF TREATING RENAL DISORDERS 2009
  • Daggen Karen Annett
RU2519124C2
PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF HEART FAILURE 2018
  • Kwak, Tae Hwan
  • Park, Woo Jin
RU2788124C2
ANTIBODIES SPECIFIC TO MMP9 2015
  • Chvatchko Missotten Ioland
  • Goffen Lorans
  • Lezher Olive
  • Dann Stiven M.
  • Pauer Kristin
  • Mondrel Kinsi
RU2714043C2
PHARMACEUTICAL COMPOSITION CONTAINING AN ANTIBODY SPECIFICALLY BINDING WITH THE N-TERMINAL OF LYSYL-TRNA SYNTHETASE AS AN EFFECTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF DISEASES CAUSED BY CELL MIGRATION 2018
  • Kwon Nam Hoon
  • Lee Jin Young
  • Kim Sunghoon
RU2749591C1
THERAPEUTIC USE OF LONG-ACTING TRIPLE AGONIST CONJUGATE HAVING ACTIVITIES ON ALL GLUCAGON/GLP-1/GIP RECEPTORS FOR TREATING LUNG DISEASE 2020
  • Lee Seon Myeong
  • Lee Jong Suk
  • Kim Jung Kuk
  • Lee Sang Hyun
  • Oh Euh Lim
  • Jo Hyo Sang
  • Park Eun Jin
  • Lim Chong Yoon
RU2829342C1
METHODS OF PREVENTING AND TREATING HEART DISEASES 2018
  • Rozenvejg, Entoni
  • Ro, Dzhejson, D.
  • Glass, Dejvid, Dzh.
RU2830232C2
ANTIBODY SPECIFICALLY BINDING TO N-TERMINAL REGION OF LYSYL-TRNA-SYNTHETASE EXPOSED ON CELL MEMBRANE 2018
  • Kim Sunghoon
  • Shim Hyun Bo
  • Kwon Nam Hoon
  • Han Dae Young
RU2739393C1
SCFV-FC DIMERS WHICH BIND TO THE TRANSFORMING GROWTH FACTOR β1 WITH HIGH AFFINITY, AVIDITY AND SPECIFICITY 2016
  • Qiu Huawei
  • Pan Clark
  • Bird Julie
RU2733286C2
NOVEL HYBRID ACTRIIB LIGAND TRAP PROTEINS FOR TREATING DISEASES ASSOCIATED WITH MUSCULAR ATROPHY 2016
  • Han Hq
  • Zhou Xiaolan
RU2834707C1
FUSION PROTEIN BASED ON ANTI-ETA AND TGF-β TRAP ANTIBODIES, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF 2020
  • Chzhan, Chen
  • Yao, Chentszyan
  • Chzhan, Khua
  • Van, Syaofyn
  • Tszin, Shutsyan
RU2832190C2

RU 2 536 223 C2

Authors

Daggen Karen Annett

Dates

2014-12-20Published

2010-04-06Filed